Trials / Conditions / Transitional Cell Carcinoma of Bladder
Transitional Cell Carcinoma of Bladder
5 registered clinical trials studyying Transitional Cell Carcinoma of Bladder.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Pilot Study of BC-819/PEI and BCG in Patients With Superficial Transitional Cell Bladder Carcinoma NCT01878188 | Anchiano Therapeutics Israel Ltd. | Phase 1 |
| Completed | PF-03446962 in Relapsed or Refractory Urothelial Cancer NCT01620970 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Phase 2 |
| Completed | A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial C NCT01326871 | Altor BioScience | Phase 1 / Phase 2 |
| Completed | B-Receptor Signaling in Cardiomyopathy NCT01135849 | Daniel Bernstein | — |
| Completed | Mitomycin C With Hyperthermia and Intravesical Mitomycin C to Treat Recurrent Bladder Cancer NCT00734994 | Mark Dewhirst | EARLY_Phase 1 |